secwatch / observer
8-K filed July 5, 2023, 7:59 PM ET CIK 0001819615
M&A confidence high sentiment neutral materiality 0.70

Clever Leaves Holdings Inc.: M&A transaction — Clever Leaves completes sale of Portuguese processing assets to Curaleaf for €2.5M

Clever Leaves Holdings Inc.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Clever Leaves Holdings Inc. completed a disposition involving Terra Verde, Lda. for EUR 2,500,000 (closed 2023-07-01).

Action
disposition
Counterparty
Terra Verde, Lda.
Consideration
EUR 2,500,000
Closing
2023-07-01
Exact text from the filing
cannabis processing facility in Setubal, Portugal (the “Transaction”). Under the terms of the APA, the total consideration paid to the Seller for the Transaction was EUR 2,500,000, which was paid in full by wire transfer of immediately available funds to the Seller’s bank account. The Transaction is one of the last steps in the Company’s previously announced
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Clever Leaves Holdings Inc. entered into APA with Terra Verde, Lda. valued at EUR 2,500,000 (effective 2023-07-01).

Action
entry
Agreement
asset purchase
Counterparty
Terra Verde, Lda.
Value
EUR 2,500,000
Effective
2023-07-01
Exact text from the filing
On July 1, 2023, an asset purchase agreement (the “APA”) was entered into by and among Clever Leaves Holdings Inc. (the “Company”) as Guarantor, Clever Leaves Portugal Unipessoal, Lda. (the “Seller” or “Clever Leaves Portugal”), a wholly-owned subsidiary of the Company, and Terra Verde, Lda. (the “Purchaser”), a wholly-owned subsidiary of Curaleaf International, part of Curaleaf Holdings, Inc.
View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR
accession 0001819615-23-000071
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.